Give companies a better pricing deal for antimicrobials, says European Parliament
This article was originally published in Scrip
Executive Summary
Companies interested in developing new antimicrobials may be pleased to hear that Members of the European Parliament are pushing to ensure they get a fair return on their investments. The European Parliament has voted for a resolution calling for the price of new antimicrobials to be de-linked from the volume of sales.